Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-Mab ADR (NQ: IMAB ) 1.480 -0.120 (-7.50%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about I-Mab ADR < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Wednesday's Intraday Session October 02, 2024 Via Benzinga Week In Review: Zenas Raises $259 Million In IPO September 28, 2024 It was a quiet week for biotech news in the Chinese market. Here is a brief overview of the notable events that occurred during this time. Zenas BioPharma staged a rare US biopharma IPO worth $259... Via Talk Markets Topics Initial Public Offering Exposures Securities Market Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent... Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga (IMAB) - Analyzing I-MAB's Short Interest May 07, 2024 Via Benzinga Looking Into I-MAB's Recent Short Interest February 07, 2024 Via Benzinga Expert Ratings for I-MAB September 25, 2023 Via Benzinga Where I-MAB Stands With Analysts September 05, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday March 18, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million February 11, 2024 I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China... Via Talk Markets 12 Health Care Stocks Moving In Friday's After-Market Session December 15, 2023 Via Benzinga Analyst Ratings for I-MAB August 18, 2023 Via Benzinga 5 Analysts Have This to Say About I-MAB June 05, 2023 Via Benzinga I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment May 26, 2023 Via Benzinga Week In Review: Two China Biopharmas Announce Billion Dollar Deals October 14, 2023 MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with... Via Talk Markets Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq September 30, 2023 While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals. Via Talk Markets Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 28, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday September 28, 2023 We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories! Via InvestorPlace Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal September 02, 2023 Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet... Via Talk Markets 7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole August 25, 2023 There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader. Via InvestorPlace Why Is TRACON Pharma (TCON) Stock Down 51% Today? April 25, 2023 TRACON Pharmaceuticals (TCON) stock is falling on Tuesday morning following an update on a legal battle with I-Mab (IMAB). Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 25, 2023 It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday! Via InvestorPlace Last Day Of Q1 March 31, 2023 Wall Street bonuses fell 26% last year. This was the biggest drop since 2008. Wall Street is estimated to be responsible for 16% of all economic activity in NYC. Wild nights out for ibankers slowing... Via Benzinga ImmuneOnco Banks On Cutting-edge Cancer Drugs To Attract IPO Cash March 31, 2023 Key Takeaways: ImmuneOnco’s main product pipeline is a cancer drug targeting a promising protein pathway, the first such drug to enter clinical tests in China, with more intensive trials due in the... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 27, 2023 On Monday, 89 stocks made new 52-week lows. Via Benzinga Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session February 06, 2023 Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 06, 2023 Via Benzinga Energizer, Children's Place And Other Big Stocks Moving Lower On Monday February 06, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga Dada Nexus, Bilibili And Other Big Stocks Moving Lower On Monday January 30, 2023 U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.